chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moments after vaccination she fainted and took minutes to come back fully aware of surroundings. She was unable to recall or state her name for minutes and eyes remained bloodshot for many minutes following recovering.
half of lower lip was swollen to about twice normal size; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and expiration date were not reported), via unspecified route of administration on 01Mar2021 (reported as Monday) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced half of lower lip was swollen to about twice normal size (about half of the lower lip) on 05Mar2021. The patient does not know if this was a possible side effect. It does not hurt but it's swollen up as if it was a huge blister and the patient have never had anything like this before. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
fewVx drops come out while administration; few drops come out onto patients arm; few drops come out onto patients arm; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th August 2022, the patient received the 2nd dose of Shingrix (intramuscular). On 18th August 2022, unknown after receiving Shingrix, the patient experienced incomplete dose administered, inadvertent exposure to vaccine and exposure via skin contact. On an unknown date, the outcome of the incomplete dose administered, inadvertent exposure to vaccine and exposure via skin contact were unknown.   Additional Information: GSK receipt date: 16-Dec-2022 Reporter's comment: The reporter was unsure if complete dose received because a small amount of vaccine seen running down patient's arm after Shingrix administration. The patient received the vaccine in left arm. The reporter did not consent to follow-up. Additional supportive information: While administering the vaccine, the reporter saw a few drops come out onto patient's arm, which led to incomplete dose administered, inadvertent exposure to vaccine and exposure via skin contact.
Extreme fatigue to the point that I could not go to work the next day. Extreme muscle and joint pain, felt paralyzed with pain whenever I moved. Chills, then overheating, nausea, (did not vomit) diarrhea, redness and heat at the injection site. Took two days to feel normal again.
never received her second Shingrix shot; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (2nd dose received 2 years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: never received her second Shingrix shot). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 02-NOV-2023 The pharmacist reported that a female customer just informed her that she never received her second Shingrix shot. The patient had the first shot over 2 years ago.  No further details were obtained as pharmacist wanted to get her call transferred to GlaxoSmithKline medical information department. The reporter consented to follow up. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The vaccine administration facility was the same as primary reporter.
I am post-menopausal and have not had a regular menstrual period for 10+ years, however, I have been experiencing breakthrough bleeding and slight cramping since receiving my second shot.
Dizzy, numb legs and seizure two days after shot. Reoccurring pressure in the head, numb hands and neuropathy,  temporary hearing loss dizziness nausea seizures continue to date. Neurologist did CT, MRI, MRA, blood work and epilepsy monitoring. No diagnosis
This case was reported by a nurse via call center representative and described the occurrence of fatigue in a 68-year-old male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced fatigue, appetite lost, injection site pain, clamminess, joint pain, injection site erythema, headache and sweating. On an unknown date, the outcome of the fatigue, appetite lost, injection site pain, clamminess, joint pain, injection site erythema, headache and sweating were recovered/resolved. It was unknown if the reporter considered the fatigue, appetite lost, injection site pain, clamminess, joint pain, injection site erythema, headache and sweating to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional (HCP) reported that the patient experienced severe headache, fatigue, loss of appetite, sweating, clammy skin, joint aches, red painful injection site, all worse for the first 34 hours after vaccination, then began to resolve. The fatigue was the longest lasting symptom, persisted for about 8 days. No further details were provided by the HCP.
About  five days later  of getting the covid 19 moderna vaccine shot, I started itching at the injection site.  Injection site began to harden a day later. As of today, 4/20/2021 the injection site is itching, hard, swollen.
Pt woke with a rash on 2/8/2015 (10 days after recieving vaccine). Did not have any fever, was acting her usual, playful self. Parents brought child in to physician office for evaluation of rash on 2/9/2015. Parents stated that the rash started on child's chin and chest and it spread from there. The rash was observed by physician, stating it was diffuse red, raised, blanching, non-pruritic rash, and the lesions on upper arms have coalesced.  The parents reported the rash had spread a lot from a few scattered spots this morning. Because patient had been to a hospital 2-3 days prior to receiving vaccine and was unsure if she had been exposed to measles, Dr was unable to determine if rash was from the vaccine or if she had contracted a wild virus. Collaboration was done through the infection control nurse at our associated hospital as well as the county health Dept and state Dept of Health regarding the possible PCR testing for measles. Because patient was asymptomatic except for the rash, she did not meet the CDC criteria for PCR testing. IgG and IgM were completed, but showed that child had developing immunity, but it was unable to determine if it was due to vaccination. As of 2/13/2015 around 4PM, parents stated that the rash had nearly faded completely and the child never did develop a fever or cough or other symptom of measles.
tachycardia; Palpitations at night; This is a spontaneous report from a contactable physician (patient). This non-pregnant 47-year-old female patient received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number ER8736) via an unspecified route of administration in the right arm on 06May2021 at 14:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, rheumatoid arthritis, and hypothyroidism, all from unknown dates and unknown if ongoing. The patient had no known allergies, had not been diagnosed with COVID-19 prior to vaccination and had not received any other vaccines in the four weeks prior to the COVID vaccine. Concomitant medications included methotrexate, sulfasalazine, levothyroxine, metformin, and hydroxychloroquine, all from unknown dates for unknown indications. The patient reported that at night of vaccination she had tachycardia around 130 at rest during sleep. After 4 days of vaccination, tachycardia continued ranging from 120-130 per minute, reported as more during sleep. She further reported palpitations at night. The events were reported as non-serious and did not require hospitalization. No treatment was received for the events. The clinical outcome of tachycardia and palpitations at night were not recovered. It was also reported that since vaccination, the patient had not been tested for COVID-19.
Patient received her Moderna COVID shot. Shortly after while speaking to the pharmacist, she started to feel dizzy and weak. Patient sat down and said she was feeling weak. She stated that she felt like she was having a panic attack.
Symptoms started off Wednesday night around 10pm with itchiness all over the body (didn?t think any of it). Thursday morning, the itchiness had ?spread? to my neck (main itch spot) and I saw a nurse practitioner to help out (prescribed benadryl and cortisone which didn?t work). Friday morning, the itchiness is still there and it?s getting annoying at this point. Saw another doctor who prescribed benadryl at night and Loratadine in the morning/afternoon, as well as colloidal oatmeal baths, new detergent and shampoo, dove unscented soap, and caladryl (did not help at all). Friday night, both arms and hands were feeling numb and tingly. Went to the ER saw a PA and he prescribed Benadryl 25mg, Pepcid 20mg, and steroids 60mg (Med....Prednisol ???) Kept up with the prescription on Saturday 25mg of Benadryl, 20mg of Pepcid and started of the 21pill package of steroids (6pills on the first day, each 4mg, and tapering off 1 pill per day for 6 days). The treatment didn?t work. The itchiness and discomfort is still very much apparent. Tuesday (05/04) afternoon I saw a primary care doctor, explained the symptoms and treatments. She believes it has something to do with the vaccine and described my symptoms to be similar to that of ?dermatographia?.  I don?t have a history of allergies or allergic reactions and the only skin ?problem? I?ve ever had is acne. No pre-existing medical conditions that could ?trigger? this
08/22/2021 I was very fatigued, felt feverish and hot, I got a rash and itchy. light hurt my eyes. I still get the rash every night about the same time night at 11pm and still on going.  09/06/2021 I went to urgent care, I am taking Zyrtec.
Severe itching on palms, soles of feet and scalp.  Occurred for several weeks and symptoms escalated over the course of several weeks to tingling, loss of mobility and paralysis.
Fever, chills, muscle aches, runny nose, lost taste & smell, headache, fatigue, cough, shortness of breath, chest pain, nausea, vomiting.
racing heart; fever; fatigue; body aches; dizziness; This non-serious case was reported by a physician via call center representative and described the occurrence of heart racing in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   In JAN-2023, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 1 day after receiving Shingrix, the patient experienced heart racing (Verbatim: racing heart), fever (Verbatim: fever), fatigue (Verbatim: fatigue), general body pain (Verbatim: body aches) and dizziness (Verbatim: dizziness). The outcome of the heart racing, fever, fatigue, general body pain and dizziness were resolved.   It was unknown if the reporter considered the heart racing, fever, fatigue, general body pain and dizziness to be related to Shingrix.     It was unknown if the company considered the heart racing, fever, fatigue, general body pain and dizziness to be related to Shingrix.   Additional Information: GSK Receipt Date: 04-APR-2023 The reporter was asked about safety of giving a patient her 2nd dose of Shingrix.  The patient received her first dose in January of 2023 and experienced the adverse events racing heart, fever, fatigue, body aches, and dizziness. The reporter was consented to follow up.
body aches all over; arm pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th May 2019, the patient received the 1st dose of Shingrix. On 7th May 2019, less than a day after receiving Shingrix, the patient experienced pain in arm. On 8th May 2019, the patient experienced general body pain. On an unknown date, the outcome of the pain in arm and general body pain were recovered/resolved.   It was unknown if the reporter considered the pain in arm and general body pain to be related to Shingrix.  Additional details were provided as follows: The patient experienced arm pain the day of the injection that got worse over the next few days and then resolved. The patient also noted extreme body aches all over that last a few days and resolved. This was 1 of 3 cases reported by same reporter.  There is a discrepancy between the outcome reported in the structured field (recovered/resolved with sequel, unknown for food poisoning) and the outcome reported in the source document (recovered, and recovering).
patient got the flu the only year he/she took flu shot; Initial information regarding an unsolicited valid non-serious social media case from a consumer (patient) on 13-Dec-2020.  This case involves a patient of an unknown demography who got the flu (influenza), while patient received INFLUENZA VACCINE.  The patient's medical history, medical treatments, concomitants and family history were not provided.  On an unknown date in 1990, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via an unknown route in unknown administration site.  On unknown date in 1990, the patient got the flu (influenza, non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE.  The patient stopped taking the flu shot and have not had flu since.  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown.  There will be no information available on the batch number for this case.
ACCORDING TO THE PATIENT, THE VACCINE ADMINISTERED SHOULDER APPEARED SWOLLEN, RED, AND WARM TO THE TOUCH AFTER APPROXIMATELY 6 DAYS FROMTHE VACCINATION DATE. THE PATIENT REPORTED THAT SHE WAS SEEN BY HER PRACTIONER AND WAS EVALUATED. THE PRACTITIONER DETERMINED THE SITE WAS INFECTED AND THE PATIENT WAS GIVEN APPROPRIATE ANTIBIOTIC THERAPY. THE PATIENT REPORTED THAT SHE HAS SINCE RECOVERED FROM THE INCIDENT WITH NO OTHER COMPLAINTS.
Information has been received from a 68 year old female patient with sulfonamide allergy and a history of blood pressure high who in approximately 2008 "about a year ago", was vaccinated with ZOSTAVAX (Oka/Merck). Then on approximately 15-DEC-2008 "about four weeks ago" the patient started to have a pain on the left side of her neck and then the lesions came out behind her ear across the front of the left side of her neck and chin. The patient reported that she saw her physician and dermatologist who told her she had developed the shingles. The patient reported that she was now on PREDNISONE and antiviral medication, name and manufacturer unspecified, and was also given PERCOCET to help the pain she was having due to the shingles. The patient reported that now the lesions were starting to go away and the pain was still there but it was not as bad as before. No further adverse effect information was reported. The patient had seen physician for medical attention. The patient was recovering from the adverse effect. No further information is available.
PATIENT RECEIVED THE PFIZER BIVALENT ON 10/05/2022, 05/12/2023 AND 08/17/2023. PATIENT SHOULD NOT HAVE RECEIVED THE PFIZER BIVALENT SHOT ON 08/17/2023
This spontaneous report as received from a nurse refers to an unspecified number of patient of unknown age and gender. On an unknown dates since 16-FEB-2015, the patients were vaccinated with an unspecified number of improperly stored doses of VAQTA intramuscularly (dose and lot number were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Nurse noticed unusual blood seepage after vaccine injection. Minor nose bleeding  5-10 days after injection..  Muscle pains for first 7 days.  Unusual hematoma at blood sample site on left arm on day 17 after injection.
slight fever sweatiness after 15-30 minutes throat started to close up, difficult to swallow and breath tingly and numb around nose this lasted for about an hour
2nd dose put her out, asleep all day; Tendinitis in thumbs, hurt more than usual; Tired; Joint pain; headache; This spontaneous case was reported by a non-health professional and describes the occurrence of SOMNOLENCE (2nd dose put her out, asleep all day), TENDONITIS (Tendinitis in thumbs, hurt more than usual), FATIGUE (Tired), ARTHRALGIA (Joint pain) and HEADACHE (headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (2nd dose put her out, asleep all day), TENDONITIS (Tendinitis in thumbs, hurt more than usual), FATIGUE (Tired), ARTHRALGIA (Joint pain) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Sleepiness, at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (2nd dose put her out, asleep all day), TENDONITIS (Tendinitis in thumbs, hurt more than usual), FATIGUE (Tired), ARTHRALGIA (Joint pain) and HEADACHE (headache) outcome was unknown.            Patient is on concomitant medication,but does not mentioned which ones.   This case was linked to MOD-2021-405920 (Patient Link).
This spontaneous report was received from a registered nurse and refers to a 4 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 01-AUG-2017, the patient was vaccinated with an improperly stored PROQUAD at a dose of 0.5 (units not specified), lot # N012491 with expiry date 17-OCT-2018 (dose number, route and anatomical location not reported) for prophylaxis. Concomitant therapies included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1707USA006208.
pain in center of back in between shoulder blades, rates as severe..has chronic low back pain Narrative: reports symptoms improved, but never went away completely. pain is not as intense now but definitly there
c/o warm to touch, sl edema & erythema;applied ice pack & took APAP;appeared more of a localized rxn;
The pt had profuse sweating, a heart rate of 140, BP 150/110, "saw white spots in eyes", arm felt numb, then heavy, some chest tightness, no shortness of breath. School nurse observed at 10:15 AM and called 911.
Medical assistant diluting covid vaccines diluted the vaccine with sterile water instead of sodium chloride. She followed the rest of the steps of preparing the vaccine correctly other than what to dilute the vaccine with. It was not caught until a few month later that this MA had been diluting the covid vaccines with the incorrect diluent. Therefore many patients, including this patient, received the covid vaccine with the incorrect diluent. Pfizer, the manufacturer, was contact regarding this and no data is available if the incorrect diluent type is supported to be stable. Therefore this dose with the incorrect diluent should be considered invalid and should be repeated. Patient has not shown any signs or symptoms since the incident. Patient appears to be well in health. Family is being notified of the incident and it will be recommended that patient get the bivalent booster as he is due for it and to revaccinate from the incident.
Patient received Pfizer vaccine #2 today.    After the vaccine, the employee reported the following symptoms:  burning sensation that started in the abdomen that traveled up to her throat within two  minutes of receiving the vaccine   Lot: EL3247  Time of Administration: 11:55  Time Symptoms Began: ~11:57   _____   Patient alerted observer who took the patient to the medical observation area.  I was alerted and responded.   Initial Assessment @ _1158_:  Patient is Patient is AAO.  The employee is sitting up on the sofa.  The employee is pink and does not appear to be in distress.  She is talking and making conversation.  She thinks its just anxiety.  I gave her some juice.  She was able to drink it without problem.  She noted that the sensation was going away.   At 11:59-12:00, it was resolved and she returned to observation.  Her time to leave the clinic was 12:10.  She was going to let me know if any new sx began.    Employee was discharged without treatment.  The RN was notified for follow up.
A lemon size swelling has appeared on my forehead. It is changing brown in color- resembles ringworm with swelling but no ring showing , metallic taste continues
Patient received a high dose Flu vaccine on 10/18/11. She returned to the pharmacy on 10/20/11 to show the pharmacist that she had a rash in the same area. (Allergic reaction).
Rotateq given 8-9-07 about 2 1/2 weeks later started with watery green mucousy stool. Lasted until 9-16-07. Stool culture - done. All negative. Better now - stool forming some. No more Rotateq.
Large approx 5-10 cm area redness, swelling localized near inject site (MMR) (had IPV same leg)
Pt @ 14 weeks pregnant, hx of seasme allergy (food ingestion) mild, no anaphylaxis now got first covid vaccination and had mild hand tingling, no CP, no SOB or throat swelling
Large, red, itchy welt around injection site. Appeared 3-4 days after shot. Began itching 8 days after.
Swelling on the cheek bone; puffy face and eyes; headache; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling on the cheek bone), EYE SWELLING (puffy face and eyes), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling on the cheek bone), EYE SWELLING (puffy face and eyes), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills). At the time of the report, SWELLING (Swelling on the cheek bone), EYE SWELLING (puffy face and eyes), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided No Treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: event details added.